0001127602-12-023455.txt : 20120801
0001127602-12-023455.hdr.sgml : 20120801
20120801193959
ACCESSION NUMBER: 0001127602-12-023455
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20120731
FILED AS OF DATE: 20120801
DATE AS OF CHANGE: 20120801
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Dittrich Thomas J.W.
CENTRAL INDEX KEY: 0001491654
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-12477
FILM NUMBER: 121001415
MAIL ADDRESS:
STREET 1: AMGEN INC.
STREET 2: ONE AMGEN CENTER DRIVE
CITY: THOUSAND OAKS
STATE: CA
ZIP: 91320-1799
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: AMGEN INC
CENTRAL INDEX KEY: 0000318154
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
IRS NUMBER: 953540776
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: ONE AMGEN CENTER DRIVE
CITY: THOUSAND OAKS
STATE: CA
ZIP: 91320
BUSINESS PHONE: (805)447-1000
MAIL ADDRESS:
STREET 1: ONE AMGEN CENTER DRIVE
CITY: THOUSAND OAKS
STATE: CA
ZIP: 91320
FORMER COMPANY:
FORMER CONFORMED NAME: AMGEN
DATE OF NAME CHANGE: 19870305
4
1
form4.xml
PRIMARY DOCUMENT
X0306
4
2012-07-31
0000318154
AMGEN INC
AMGN
0001491654
Dittrich Thomas J.W.
ONE AMGEN CENTER DRIVE
THOUSAND OAKS
CA
91320
1
VP, Finance & CAO
Common Stock
2012-07-31
4
M
0
25000
69.83
A
38721
D
Common Stock
2012-07-31
4
M
0
3000
42.13
A
41721
D
Common Stock
2012-07-31
4
M
0
2000
50.44
A
43721
D
Common Stock
2012-07-31
4
M
0
2150
58.43
A
45871
D
Common Stock
2012-07-31
4
S
0
32150
82.687
D
13721
D
Nqso (Right to Buy)
69.83
2012-07-31
4
M
0
25000
0
D
2007-05-15
2013-05-15
Common Stock
25000
0
D
Nqso (Right to Buy)
42.13
2012-07-31
4
M
0
3000
0
D
2009-04-29
2015-04-29
Common Stock
3000
0
D
Nqso (Right to Buy)
50.44
2012-07-31
4
M
0
2000
0
D
2010-04-28
2016-04-28
Common Stock
2000
2000
D
Nqso (Right to Buy)
58.43
2012-07-31
4
M
0
2150
0
D
2011-04-26
2020-04-26
Common Stock
2150
4300
D
The price reported is an average price. The prices ranged from $82.67 to $82.75 per share. Full information regarding the number of shares sold at each separate price within the range set forth above is available upon request by the SEC, the issuer or a security holder of the issuer.
The shares include the following Restricted Stock Units (RSUs) granted under the Company's equity plans: 286 RSUs which fully vest on 4/28/2013; 615 RSUs which vest in annual installments of 307 on 4/26/2013 and 308 on 4/26/2014; 1,714 RSUs which vest in annual installments of 565, 566 and 583 on 4/25/2013, 4/25/2014 and 4/25/2015, respectively; and 1,400 RSUs which vest in two equal installments of 462 each on 4/27/2014 and 4/27/2015 and one installment of 476 on 4/27/2016. Vested RSUs will be paid in shares of the Company's common stock on a one-to-one basis.
These shares include 7 Dividend Equivalents (DEs) granted pursuant to the Amgen Inc. 2009 Equity Incentive Plan and subject to a qualifying dividend reinvestment plan. DEs are credited on the reporting person's unvested RSUs and are paid out in shares of the Company's common stock on a one-to-one basis according to the vesting schedule, along with a cash payment for any remaining fractional share amount.
/s/ Thomas J.W. Dittrich
2012-07-31